Article Information
History
- July 25, 2017.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- T. Wassmer*1,
- L. Evans*2,
- G. Fraser3,
- J. Smith1,2,
- M. Perkinton3,
- A. Billinton3 and
- F.J. Livesey1,2,#
- 1Talisman Therapeutics, Babraham Research Campus, Cambridge, CB22 3AT
- 2Gurdon Institute and Department of Biochemistry, University of Cambridge, CB2 1QN
- 3AstraZeneca Neuroscience Innovative Medicines and Early Development, Granta Park, Cambridge, CB21 6GH
- ↵#Author for correspondence: rick{at}gurdon.cam.ac.uk